Introduction and aims of the study: Postpartum haemorrhage (PPH) is the leading cause of maternal death worldwide. The most common cause is uterine atony (UA), where the uterus is unable to contract properly. All therapeutic measures are based on the same principle which is uterine contraction stimulation. FemoStop® was developed for femoral artery/vein compression after percutaneous endovascular interventions and has proven to be reliable in achieving hemostasis in this context.